SCHEMBL21991031

SCHEMBL21991031

CC[C@H]1C[C@@H](Sc2cc(C(=O)Nc3ccc(F)c(Cl)c3)ccc2F)C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
KCNQ3 O43525 1/20 0.47
KCNQ2 O43526 1/20 0.47
KCNE1 P15382 1/20 0.47
KCNQ1 P51787 1/20 0.47
TSHR P16473 1/20 0.47
CHRM1 P11229 1/20 0.47
MAOB P27338 3/20 0.46
MAOA P21397 2/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
CCR2 P41597 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17792108 0.86 NPC1 (0.51) NPC1RAB9ASMN1; SMN2KCNQ3KCNQ2
SCHEMBL17784009 0.85 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KCNQ3KCNQ2
SCHEMBL19473198 0.85 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KCNQ3KCNQ2
SCHEMBL17792166 0.85 NPC1 (0.54) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL21991727 0.85 NPC1 (0.54) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL17784013 0.84 NPC1 (0.48) NPC1RAB9ASMN1; SMN2KCNQ3KCNQ2
SCHEMBL19473180 0.84 NPC1 (0.55) NPC1RAB9ASMN1; SMN2KCNQ3KCNQ2
SCHEMBL17792089 0.83 NPC1 (0.50) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL17792162 0.83 NPC1 (0.52) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL17784053 0.83 NPC1 (0.52) NPC1RAB9AKCNQ3KCNQ2KCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227262-B1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS INC (US) 2020-05-13 EP disclosed